Security Snapshot

Rein Therapeutics, Inc. - Common Stock, $0.001 par value per share (RNTX) Institutional Ownership

CUSIP: 00887A204

13F Institutional Holders and Ownership History from Q4 2022 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

47

Shares (Excl. Options)

32.4MFull value: 32,398,519 · shares · 30 Sep 2026

Price

$0.80

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+153,161
Value change
-$59,630
Number of holders
47
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
84,905,660
SEC-reported price per share
$0.80
Insider filing price
$0.80
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • RNTX - Rein Therapeutics, Inc. - Common Stock, $0.001 par value per share is tracked under CUSIP 00887A204.
  • 47 institutions reported positions in Q3 2026.
  • 8 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 58 to 47 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $42.33MFull value: $42,325,116 · USD · 30 Jun 2026
    to
    $26.04MFull value: $26,041,413 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 47 institutions filings for Q3 2026.

Open SEC evidence

Security key

00887A204

13F reference period

Q3 2026

13F holders

47

13D/G owners

8

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
8
Security
RNTX
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BIOS Fund I, LP 10% $10,136,753 7,797,502 BIOS CAPITAL MANAGEMENT, LP 06 May 2026
Voss Capital, LP 6.6% -61% $5,883,235 +$1,235,508 5,656,957 +27% Voss Capital, LP 30 Jun 2026
Funicular Funds, LP 6.7% $6,753,500 5,195,000 Funicular Funds, LP 01 May 2026
ADAR1 Capital Management, LLC 5.3% $4,455,000 4,500,000 ADAR1 Capital Management, LLC 30 Jun 2026
Lynwood Capital Management Inc. 5% -18% $4,237,695 -$464,805 4,280,500 -9.9% Lynwood Capital Management Inc. 30 Jun 2026
LYTTON LAURENCE W 4.9% -15% $4,196,242 -$258,758 4,238,628 -5.8% LYTTON LAURENCE W 30 Jun 2026
BIOS Fund III, LP 6.2% $5,156,801 3,683,429 BIOS EQUITY PARTNERS III, LP 05 May 2025
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 4.4% $1,758,017 960,665 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 04 Nov 2024
As of 30 Sep 2026, 47 institutional investors reported holding
32.4MFull value: 32,398,519 · shares · 30 Sep 2026
shares of Rein Therapeutics, Inc. - Common Stock, $0.001 par value per share (RNTX). This represents 38% of the company’s total
84.91MFull value: 84,905,660 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
37%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Voss Capital, LP 6.9% 5,850,000 0.26% $4,703,400
Cable Car Capital, LP 6.1% 5,195,000 1.2% $4,176,780
VANGUARD CAPITAL MANAGEMENT LLC 3.9% 3,351,812 0% $2,694,857
BIOS Capital Management, LP 3.5% 2,982,375 7% $2,397,830
Ikarian Capital, LLC 3.5% 2,950,000 0.47% $2,371,800
Velan Capital Investment Management LP 2% 1,700,000 1.3% $1,366,800
GREAT POINT PARTNERS LLC 2% 1,663,144 0.35% $1,337,168
Prosight Management, LP 2% 1,660,197 0.26% $1,334,798
Senvest Management, LLC 1.4% 1,230,895 0.03% $989,640
Bleichroeder LP 1.2% 1,000,000 0.08% $804,000
GEODE CAPITAL MANAGEMENT, LLC 0.98% 832,979 0% $669,773
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 0.6% 511,610 0.05% $411,334
VANGUARD FIDUCIARY TRUST CO 0.58% 493,826 0% $397,036
STATE STREET CORP 0.45% 379,604 0% $305,202
Texas Capital Bank Wealth Management Services Inc 0.42% 360,758 0.01% $290,049
Sigma Planning Corp 0.42% 357,477 0.01% $287,412
GAGNON SECURITIES LLC 0.27% 229,070 0.03% $184,172
Palogic Value Management, L.P. 0.21% 180,000 0.05% $144,720
ABS Investment Management LLC 0.21% 175,000 0.06% $140,700
MARSHALL WACE, LLP 0.19% 158,435 0% $126,748
XTX Topco Ltd 0.14% 121,208 0% $97,451
Warberg Asset Management LLC 0.11% 96,000 0.02% $78,038
Savant Capital, LLC 0.07% 61,056 0% $49,090
Vanguard Global Advisers, LLC 0.06% 50,991 0% $40,997
MERCER GLOBAL ADVISORS INC /ADV 0.06% 50,461 0% $40,571

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
16
Headline period
Q3 2026
Rows shown
1-16 of 16
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 32,398,519 $26,041,413 -$59,630 $0.80 47
2026 Q2 40,716,277 $42,325,116 +$30,310,499 $1.04 58
2026 Q1 11,396,524 $14,839,714 +$855,214 $1.30 45
2025 Q4 10,799,701 $12,545,188 +$2,685,239 $1.16 46
2025 Q3 8,489,234 $9,760,613 +$2,095,461 $1.14 39
2025 Q2 6,657,209 $9,543,969 +$863,809 $1.40 35
2025 Q1 6,017,421 $10,645,603 +$584,856 $1.77 37
2024 Q4 5,679,222 $13,062,350 -$2,786,804 $2.30 30
2024 Q3 4,605,051 $16,285,431 -$1,010,220 $3.54 29
2024 Q2 4,894,669 $13,494,162 +$5,623,418 $2.77 27
2024 Q1 1,688,450 $10,954,455 +$3,910,201 $6.63 22
2023 Q4 1,063,685 $3,241,840 +$183,775 $3.05 19
2023 Q3 1,045,511 $1,588,393 +$34,111 $1.52 15
2023 Q2 1,022,688 $1,829,841 -$43,089 $1.79 16
2023 Q1 1,050,566 $1,302,967 -$651,889 $1.24 17
2022 Q4 1,356,571 $3,214,622 +$3,214,622 $2.37 16
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .